Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia

Michael L. Graham,Barbara L. Asselin,James E. Herndon,Janet R. Casey,Sara Chaffee,G. Ciocci,Charles Daeschner,AR Davis,Stuart H. Gold,Edward C. Halperin,Mary J. Laughlin,Paul Martin,Janice Olson,Joanne Kurtzberg

Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia

1998

Michael L. Graham
Barbara L. Asselin
James E. Herndon
Janet R. Casey
Sara Chaffee
G. Ciocci
Charles Daeschner
AR Davis
Stuart H. Gold
Edward C. Halperin
Mary J. Laughlin
Paul Martin
Janice Olson
Joanne Kurtzberg

Toxicity, pharmacology and feasibility of administration of PEG- L -asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia

Keywords:

Acute lymphocytic leukemia
PEG ratio
Bone marrow
Immunology
Medicine
Asparaginase
Pharmacology
Transplantation
Toxicity
Chemotherapy
Pharmacokinetics
Hypoalbuminemia
Surgery
Pancreatitis
Complication

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations